The Latest: India drug maker, Russia agree on virus doses (from @AP)
NEW DELHI — An Indian pharmaceutical company and Russia’s sovereign wealth fund have agreed to distribute 100 million doses of the Russia’s experimental Sputnik V vaccine in India.
The Russian Direct Investment Fund (RDIF) says it had paired with Indian company Dr. Reddy’s Laboratories Ltd. The pharmaceutical company will be conducting phase three trials in India to meet the country’s regulatory requirements.
Press secretary Arseniy Palagin confirmed the 100 million doses of the experimental vaccine were meant for “population wide use” as long as they met regulatory requirements and clinical trials were successful.
Indian officials said last week that Russia had asked for assistance for the vaccine to be manufactured by Indian companies and the government was facilitating this.
— India’s virus cases pass 5 million, challenging health care system. The world’s second-most populous country has added more than 1 million cases this month.
— Iowa governor won’t budge on mandating masks even as virus deaths rise. Gov. Kim Reynolds refuses to let city officials enforce local mandates, even as state maintains one of the highest coronavirus positivity rates.
— Doubts persist as NYC’s hybrid school year is set to start. It begins remotely Wednesday in a soft opening for more than 1 million kids and prologue to return for some to physical classrooms next week.